Phreesia is downgraded from buy to hold after plunging to all-time lows post-Q4 2026, driven by reduced revenue guidance and significant market headwinds. PHR cut FY2027 revenue guidance by 6.7% at ...
Good evening, ladies and gentlemen. And welcome to the Phreesia Third Quarter Fiscal 2025 Earnings Conference Call. At this time, all participants are in a listen only mode. We will provide ...
Phreesia Inc. (NYSE:PHR) shares slipped Friday despite a stronger-than-expected second quarter. The healthcare software firm posted earnings of 1 cent per share, topping forecasts for a 6 cent loss, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results